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Background: It has been suggested that autism spectrum disorder (ASD) might be a “comorbid” 
condition in selective mutism (SM). 
Methods: In this retrospective study, we examined medical records of children with SM 
diagnosis (n=97) at a medical center specializing in assessment of ASD. 
Results: Mean age for onset of SM symptoms was 4.5 years and mean age at SM diagnosis 
was 8.8 years. SM was more common among girls (boy:girl ratio=2.7:1). We found that 63% 
of the study group had an ASD (no gender difference). The SM group with combined ASD had 
later onset of symptoms, higher age at diagnosis, more often a history of speech delay, and a 
higher proportion of borderline IQ or intellectual disability.
Conclusion: The results highlight the risk of overlap between ASD and SM.
Keywords: selective mutism, autism spectrum disorders, Asperger syndrome, autistic disorder
Introduction
Selective mutism (SM) is described in the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth edition (DSM-IV) and Fifth edition (DSM-5) as a rare anxiety disor-
der, characterized by a consistent failure to speak in specific social situations in which 
there is an expectation of speaking, despite speaking in other situations1,2 (Americal 
Psychological Association 1994; 2013). In 1877, Kussmaul described SM and he used 
the term aphasia voluntaria to underline the awareness and the free will not to speak.3 
In 1934, Tramer3 introduced the concept of elective mutism that continued emphasiz-
ing the voluntariness in not speaking in certain situations. Throughout its history, SM 
has been described as an oppositional trait with an unwillingness to speak rather than 
a single diagnosis.3 In the publication of DSM-IV,1 the diagnosis of SM was included, 
which underlines the lack of speech in certain situations. The shift broadened the diag-
nosis phenomenology, from a voluntarily controlled and defiant behavior to a pattern 
of reaction in response to an overwhelming or threatening context change.4 The failure 
to speak cannot be explained by lack of language skills. The duration of disturbance 
should be at least 1 month. The disorder should not be categorized as a communication 
disorder, pervasive developmental disorder (PDD), schizophrenia, or other psychotic 
disorder.1,2 In the DSM-5, SM is categorized under the category of Anxiety Disorders, 
and this marks an increased focus on supposed underlying social anxiety problems.
Communication patterns in SM vary from total absence of speech in almost all 
situations to lack of speech in only certain situations. The most common situations 
for the appearance of SM symptoms are in school, where the teacher is the person 
that the child is least likely to talk to.5 Sometimes the child can talk to select students, 
sometimes to nobody at all. Commonly, the child speaks normally at home with the 
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family, but the opposite situation, where the child speaks at 
school but not at home, has also been described.6
Onset of SM symptoms is reported to be 2.7–4.1 years.4 
Usually, the symptoms are not noticed until the child starts 
primary school, which might be explained by the increased 
social demand and increased demands for performance, 
making the symptoms more obvious.3 The long interval 
between symptom onset and detection of problems is prob-
ably explained by the fact that children often speak without 
any problem in the home environment.
The reported prevalence rates vary between 0.2% and 
0.8%.4,7–9 SM is reported to be more common among girls 
than boys, with an estimated girl:boy ratio varying between 
2.6:1 and 1.5:1.3 SM is described as a condition in children 
but can also be recognized in adults; however, the symptoms 
are more often categorized as social phobia,3 under the 
anxiety disorders umbrella. A few longitudinal studies of 
SM have been performed and the persistence of symptoms 
varies in the literature, from months to several years. There 
is usually remaining shyness; social anxiety;3 and lack of 
self-confidence, independence, achievement, and social com-
munication abilities into teenage and adult life.6,10
In addition to anxiety, other associated symptoms/comor-
bidities have also been reported, such as speech and language 
problems,11,12 obsessive compulsive disorder,13 Fragile X 
syndrome,6 attention deficit hyperactivity disorder (ADHD),4 
depression, panic disorder, disassociate disorders, and other 
somatic complaints.3 Kristensen reported an association 
between SM and developmental disorders relating to commu-
nication, learning, motor skills in a study of 54 children with 
SM. She found that 7% of the participants also fulfilled the 
criteria for Asperger syndrome (AS), and an additional 7% met 
the criteria for mild intellectual disability (ID).12 Anderson and 
Thomsen14 found in a group of 37 children with SM that 4 of 
them had AS. Furthermore, autism spectrum disorder (ASD) 
has been found to occur more frequently in SM families.14
The purpose of the present study was to examine the 
prevalence of ASD in a relatively large clinical sample of 
children with SM who were referred to a center specializing 
in the assessment of neurodevelopmental disorders. Further-
more, a study on joint attention, a specific aspect of social 
communication, reported fewer episodes of joint attention 
in the SM group than in comparison group.15 More girls 
than boys are affected by SM;3 however, if that is the case in 
children with comorbid SM and ASD is not clear. A second 
aim was therefore to examine possible gender differences 
with regard to presence of ASD.
Participants and methods
Procedure
All individuals at the Child Neuropsychiatry Clinic (CNC) 
in Gothenburg who had received a DSM-IV diagnosis of SM 
between 2003 and 2014 were eligible for participation in the 
study. CNC is a regional clinic in Gothenburg, West Sweden, 
focusing on the assessment of neurodevelopmental disorders 
(autism, ADHD, Tourette syndrome, etc), and at that period 
also on the assessment of SM, in children and adolescents. 
All data were retrieved from medical records including the 
diagnosis, except for in some cases where there was an ASD 
diagnostic re-evaluation based on the medical records at the 
time of the study, by the second author SZ, who was the 
clinical doctor for a large proportion of the study group. The 
time period was chosen to coincide with the introduction of 
a computerized medical record system at the CNC in 2003, 
making data retrieval easier.
Participants
One hundred and six individuals were diagnosed as having 
SM during the selected time period at the CNC. Nine indi-
viduals (4 girls and 5 boys) were excluded because there was 
some uncertainty about diagnosis or because the medical 
records contained too scanty information, leaving a total of 
97 individuals (71 girls and 26 boys) who were included in 
the study. The age at assessment in the CNC ranged from 
4 to 18 years (median=8 years).
The clinical/diagnostic assessment
The clinical/diagnostic assessments had been performed by a 
team that included a medical doctor/child psychiatrist and a 
clinical psychologist at CNC, both with extensive experience 
in the field of SM and ASD, including diagnostic work-up. The 
diagnoses were based on all the available information provided 
by the files, the clinical interview, and the clinical impression 
according to the LEAD-principle (Longitudinal, Expert, All, 
Data).16 All individuals were examined individually, and at 
least 1 parent was interviewed. The interview always cov-
ered language development, onset of SM symptoms, age at 
diagnosis, and whether or not the child had been exposed to 
a non-Swedish language environment at home. The clinical 
assessment procedure included instruments regularly used in 
clinical practice, such as DSM-IV checklists, parent/teacher 
questionnaires (the 5–15 questionnaire17), and The Autism 
Spectrum Screening Questionnaire18 in most cases. The choice 
of instrument was dependent on the complexity of the condi-
tion (the more complex the clinical picture, the more extended 
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assessment) or if the child was referred to the clinic for 
second opinion evaluation (meaning that several instruments 
had already been used at the referral clinic). However, these instru-
ments were not used as a final decision for diagnosis. The doctor 
made the final diagnostic decision after consultation with the clini-
cal psychologist. The diagnoses of SM and autistic disorder (AD) 
were based on the DSM-IV criteria.1 PDD not otherwise specified 
(PDD-NOS)/atypical autism was diagnosed when DSM-IV cri-
teria for AD were met. For the diagnosis of AS, the Gillberg and 
Gillberg criteria14 were applied. The term ASD was used as an 
umbrella term to include children with AD, PDD-NOS/atypical 
autism, and AS. Children with autistic features (meeting 2 or 3 AD 
criteria) were described as having autistic features but they were 
not included in the ASD-group. A combination of ASD and SM 
diagnosis was given when the symptoms could not be explained 
by one of the separate conditions alone; for example, when the 
child was reported to have absence of speech in certain situations 
but not in others in combination with non-verbal communication 
deficits and extreme adherence to routines.
Assessment of cognitive function
About half the study group had been cognitively assessed 
with an IQ test (Wechsler Preschool or Primary Scale of Intel-
ligence, Wechsler Intelligence Scale for Children, Wechsler 
Adult Scale of Intelligence19–21) or, in children with a mental 
age below what is required in the Wechsler scale test, a 
developmental test (Griffiths’ Developmental Scales I and/or 
II22) was used. In some cases an evaluation of the cognitive 
function was based on the overall clinical impression of the 
child. All assessments (including evaluation) of cognitive or 
developmental function had been performed by a licensed 
psychologist either at the referral clinic or at the CNC. Cogni-
tive level group status was assigned in the following manner: 
Average Intellectual Functioning (AIF)=IQ84, Borderline 
Intellectual Functioning (BIF) IQ 70–84, and ID=IQ70.
Statistical analysis
Descriptive analyses were used to obtain information on 
means and SD for continuous variables, and frequencies and 
percentages for categorical variables. The non-parametric test 
Chi-squared was applied for analysis of nominal data and Mann–
Whitney U-test was applied for analysis of interval data.
Ethical approval
The study was approved by the Medical Ethical Committee 
of the University of Gothenburg. This is an anonymized 
baseline register clinical audit study and patient consent was 
not required at this stage, but for the ongoing follow-up study, 
there is ethics approval with written informed consent. All 
procedures performed in the study were in accordance with 
the ethical standards of the institutional research committee 
and with the 1964 Helsinki declaration and its later amend-
ments or comparable ethical standards.
Results
Comorbid ASD in the SM study group
Of the 97 individuals with SM, 63% (n=61) had ASD, 
hereinafter referred to as the SM+ASD group. Of these, 28 
(29%) had AD, 29 (30%) had atypical autism/PDD-NOS, and 
4 (4%) had AS. A further 20% (n=19) had autistic features 
that were “subclinical”, but, nevertheless, sufficiently marked 
to have an impact on everyday life. No ASD symptoms at 
all were found in 17% (n=17). The group with a few autistic 
features, but not enough for a formal ASD diagnosis, and 
the group with no ASD symptoms were collapsed and are 
referred to as the SM−ASD group (n=36, 37%).
Delayed or abnormal speech 
development
For 17% (n=14), no information about speech development 
was recorded. About 1 in 4 (n=22/83, 27%) of the total study 
group was reported in medical records to have had delayed 
or abnormal speech development (Table 1). There was a 
trend that the SM+ASD group (n=17/51, 33%) had more 
delayed/abnormal speech development than the SM−ASD 
group (n=5/32, 16%) but this difference was not significant 
(p=0.0752).
Onset of SM symptoms
The mean age of onset of symptoms (n=92, missing informa-
tion in 5 cases) was 4.5 years and the range was 1–16 years 
of age. Only 4 cases were reported to have symptom onset 
after 10 years of age. The onset of symptoms was very often 
reported to be related to start of preschool (age 2–4 years) or 
when the child changed preschool group, particularly from 
a smaller to a larger group or at start of school (in Sweden 
about 7 years of age). Mean age for onset of SM symptoms 
in the SM+ASD group was reported to be 5.0 years (SD=2.7) 
compared to 3.7 years (SD=1.9) in the “SM Only” group 
(U=694, p=0.011).
Age at SM diagnosis
The mean age at SM diagnosis in the total study group was 
8.8 years (SD=3.6), with an age range between 4 and 18 years 
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of age. Mean age of SM diagnosis in the SM+ASD group 
was 9.9 years (SD=3.4) and in the “SM Only” group 6.9 years 
(SD=3.1) (U=501, p0.001).
Non-Swedish-speaking home 
environment
Twenty-seven percent (26/97) of the children were living 
in a home where more than one language was spoken, and 
this was more common among males than females (χ²=4.35, 
p0.05). One in 5 in the SM+ASD group had such a home 
environment compared with almost 2 in 5 in the “SM Only” 
group (X 2 [1, N=97, p=0.057]).
Clinical SM characteristics at assessment
SM symptoms manifested outside the home in all cases 
(100%). Five percent (n=5) had symptoms of SM in the 
home as well. These children were described as extremely 
shy and avoiding contact with others, alternatively not talk-
ing to a specific member of the family. Four of these had 
SM+ASD.
General cognitive function
In the total study group, 62% (n=60) had AIF, 22% had BIF, 
and 16% had ID. There was a significantly lower cognitive 
function in the SM+ASD group compared with the SM−ASD 
group (U=572, p0.001). In the SM+ASD group, 27 (44%) 
had AIF, 19 (31%) had BIF, and 15 children (25%) had ID. 
In the SM+ASD group, we found that 33 children (92%) had 
AIF, 2 (6%) had BIF, and 1 had ID (3%) (p=0.001).
Gender difference
There were 71 girls and 26 boys (girl:boy ratio=2.7:1 
[p0.001]) in the total study group. No significant gender ratio 
difference was found between the SM+ASD group (43 girls, 
18 boys, girl:boy ratio=2.4:1) compared with the SM−ASD 
group (28 girls, 8 boys, girl:boy ratio=3.5:1, Table 1). We found 
no gender differences regarding speech development, delay/
abnormal development, onset of symptoms, age of diagnosis, 
or cognitive functioning. The only gender difference found 
was that more boys than girls were living in families where 
Swedish was not the first language.
Discussion
In this study of a clinical group of children who were diag-
nosed with SM and assessed at a center for neurodevelop-
mental disorders, 63% also met criteria for ASD. A further 
20% had subclinical autistic traits. This is a significantly 
higher prevalence than found in Kristensen’s study,12 or in the 
Anderson et al study14 which are the only 2 systematic clinical 
studies, to our knowledge, that set out to study the preva-
lence of neurodevelopmental disorders in SM. Kristensen 
found that 7% of her group had AS, which is similar to the 
rate reported by Anderson et al.14 Our much higher rate of 
children with ASD in the present study most likely reflects 
Table 1 Clinical characteristics of 97 children with SM, SM+ASD, or SM−ASD
Total SM, 
N=97, n (%)
SM−ASD, 
n=36, n (%)
SM+ASD, 
n=61, n (%)
Comparison between 
SM−ASD and  
SM+ASD, p-value
Girl:boy ratio 71:26 43:18 28:8 434
Delayed speech development (n=83) 22 (27) 5 (16) 17 (33) 0.121
Age at onset of SM symptoms, mean (95% CI) (n=92) 4.5 (4.0–5.0) 3.6 (3.0–4.2) 5.0 (4.3–5.8) 0.006
Intellectual function
Average or above average IQ ($85) 60 (62) 33 (92) 27 (44) 0.001
Borderline IQ (71–84) 21 (22) 2 (6) 19 (31) 0.004
Intellectual disability (#70) 16 (16) 1 (3) 15 (25) 0.004
ASD
Autistic disorder 28 (29) 0 28 (46) 0.001
Asperger syndrome 4 (4) 0 4 (7) 0.117
PDD-NOS 29 (30) 0 29 (48) 0.001
Autistic traits (no diagnosis) 19 (20) 19 (53) 0 (0) 0.001
Context of symptoms outside home 97 (100) 36 (100) 61 (100) 1.0
Context of symptoms in home 5 (5) 1 (3) 4 (7) 0.377
Non-Swedish language home environment 26 (27) 14 (39) 12 (20) 0.057
Age at diagnosis of SM, mean (95% CI) 8.8 (8.0–9.5) 6.9 (5.8–7.9) 9.9 (9.0–10.8) 0.001
Abbreviations: ASD, autism spectrum disorder; IQ, intellectual quotient; NOS, not otherwise specified; PDD, pervasive developmental disorder; SM, selective mutism.
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
20
9.
11
6.
21
 o
n 
15
-J
an
-2
02
0
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2018:14 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1167
Are ASDs comorbid in SM
that the participants were referred to CNC, a clinic that is well 
known for their expertise in ASD. This means that our results 
correspond well with those children who have an additional 
neurodevelopmental disorder and probably not with entire 
SM population. Additionally, this is a retrospective chart 
review study with the limitations that such studies entail. 
However, the professionals responsible for the chart records 
were extremely experienced clinical experts in the field of 
autism and general child neuropsychiatry, and their infor-
mation entries in the medical records therefore were quite 
homogeneous. The reason why the individuals with ASD had 
not been previously “properly” diagnosed as suffering from 
ASD cannot be specified with certainty, but we believe that 
the combination of 1) the general tendency for clinicians to 
only provide one major “overarching” diagnosis and 2) the 
very obvious (indeed often dramatic) symptom of muteness 
had led to a primary diagnosis of “only” SM. Also, up until 
very recently, double diagnosis has not been strongly sup-
ported in the guidelines of the diagnostic manuals, such as the 
DSM. Both SM and ASD have been regarded by many (both 
clinicians and researchers) as homogeneous, indeed mutually 
exclusive, disorders with little or no comorbidity. We would 
argue that our findings are important in that they point to the 
need toward always looking out for symptoms of autism in 
cases with SM, and to consider the possibility that the “symp-
tom” of SM might not be extremely rare in autism.
It has been suggested that the anxiety experienced by 
children with SM makes them refuse speech because they are 
“frozen with fear”.24 Our study group with SM+ASD was more 
often described as demonstrating lack of social skills/social 
interest, and that refusal to speak reflected a stubborn refusal 
rather than shyness. There might be subgroups within the SM 
patient group and those who were assessed at our clinic are 
particularly the subgroup with SM and a comorbid ASD.
It is probably important for the group of individuals who 
meet the criteria for both SM and ASD that both diagnoses 
be considered. It is likely that the principles for intervention 
in ASD (eg, preparation for new events, visual support for 
daily structure, and to make daily activities predictable) and 
the knowledge of communication problems seen in ASD (that 
it always includes impairments in the social use of language) 
are beneficial for the comorbid SM+ASD group. However, 
it is not known whether treatment directed at SM should be 
differently designed when autism is concurrent.
The mean age of SM symptom onset was 3.7 years in the 
SM−ASD group, and 18 months later in the SM+ASD group. 
Onset of symptoms in the SM−ASD group is consistent with 
previous research where an onset between 2 and 5 years 
of age has been reported.25 Our finding of a considerably 
later onset of SM symptoms in the SM+ASD group could, 
perhaps, be explained by SM being “due to” autism or SM 
being overshadowed by other ASD symptoms. Overall, the 
findings indicate an early age of onset of SM, estimated to 
be when the child is in preschool, aged 2–5 years.
Early onset of symptoms does not lead directly to early 
diagnosis. The mean age for SM diagnosis was about 3 years 
after SM symptom onset and almost 5 years later for the 
combined SM+ASD. This implies that several years of 
intervention and treatment are missed, which are important 
years in a child’s development of social communication 
and interaction. It is also important to highlight that the age 
range for the diagnosis of SM ranged from 4 to 18 years. For 
some children, it may be more than 4 years between onset of 
symptoms and diagnosis time.
We found an uneven girl:boy ratio, with more girls than 
boys presenting the condition. This was also reflected in the 
SM+ASD group. Compared with other neurodevelopmental/
neuropsychiatric disorders, this higher prevalence of SM in 
girls is perhaps somewhat surprising. It is possible that the 
designed diagnostic criteria for SM could fit a more typical 
girls “prototype” with introverted symptoms, such as quiet 
and restrained behavior. However, our results are in line 
with other studies that show all anxiety disorders occur more 
frequently among females than males.25
All reported SM symptoms were expressed outside home, 
which is to be expected since the social setting described in the 
criteria is outside home (school). Interestingly, there was a small 
subgroup (only about 5% of the total group) who also presented 
major SM symptoms at home, in familiar settings toward a family 
member, and that all except 1 of these children also had ASD.
Immigration and exposure to several languages during 
the early years has been reported to be a possible risk factor 
for developing SM.27 We could not confirm a higher than 
average rate of this type of background in the SM group 
compared with the general population of children under 
18 years of age (27% in the SM group versus 30% in children 
under 18 years of age in the general population, Statistics 
Sweden28). However, there was a trend that the SM+ASD 
group more often had a bilingual background compared with 
the SM+ASD group, indicating that in the latter group, addi-
tional neurodevelopmental factors might play an etiological 
role in the development of SM.
The level of cognitive function was average in more 
than half of the study group but more than one-third of the 
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study group had a borderline IQ or an ID. Prevalence rates 
for ID vary between 0.5% and 2%29–31 and the estimated 
rate for borderline IQ is 10%–15% in Swedish primary 
school children.31 Our findings suggest that low cognitive 
function may be more common in the SM group. It has 
been suggested that children with lower intelligence or 
learning problems perceive school as more difficult, and 
because of that, they are less likely to engage in speech24 
and it is probable that low cognitive ability, combined with 
difficulties, such as autism, can affect the development of 
SM. On the other hand, the lower cognitive ability might 
be due to having professionals administer the test, which 
is the standard practice. In a study by Klein et al, children 
with SM scored higher on parents-administered test than 
on professional-administered test measuring receptive and 
expressive language, albeit not on narrative comprehen-
sion test.33
Our results not only show an overlap between SM and 
ASD but also IDs. A concept that might better capture 
this overlap is Early Symptomatic Syndromes Eliciting 
Neurodevelopmental Clinical Examinations (ESSENCE). 
The concept was founded by Gillberg34 and aims at the 
whole group of early-onset neurodeveloping problems, 
regardless of diagnosis, and emphasizes that these problems 
often overlap with each other and that there is a need for 
clinicians to be alert aware of this. Because of the overlap 
between symptoms, patients are sometimes diagnosed with 
1 or 2 diagnoses at one point and a third at a later stage. 
Disorders included in the ESSENCE concept include, but 
are not limited to, ASD, ADHD, IDs, language disorders, 
and motor disorders. An ESSENCE approach would mean 
that occurring SM symptoms constitutes a marker to draw 
attention to other neurodevelopmental abnormalities, such 
as autism or IDs.
Strength and limitations
The study is based on retrospective chart reviews, which 
implies some uncertainty as to the quality of the data obtained 
at the time for diagnostic assessment. All participants were 
diagnosed (or re-evaluated) at one specific clinic, meaning 
that the data were assessed, analyzed, and interpreted by the 
same clinical group of professionals, increasing the inter-rater 
reliability. The study group was a clinic-based cohort and the 
representativeness of the cases cannot be confirmed.
In comparison to other clinical studies, this study has a 
special position in terms of number of participants, which 
makes the study unique. Previous studies have included SM 
groups of 37–54 individuals.11,13 The largest cohort ever 
included 100 participants,10 but there was no focus on ASD 
in that study.
Disclosure
The authors report no conflicts of interest in this work.
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